From: PTENgenomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity
n=43
Median age (range, years)
63 (47–76)
Median follow-up (months)
62
Median PSA at surgery (ng.ml-1)
8.7
Biochemical recurrence
12 (28%)
Gleason score
≤6
13 (30%)
=7
23 (54%)
≥8
7 (16%)
Pathological stage
≤T2
27 (63%)
≥T3
16 (37%)